Describing essential habitat is an important step toward understanding and conserving harvested species in ecosystem-based fishery management. Using data from fishery-independent ichthyoplankton, groundfish surveys, and commercial fisheries observer data, we utilized species distribution modeling techniques to predict habitat-based spatial distributions of federally managed species in Alaska. The distribution and abundance maps were used to refine existing essential fish habitat descriptions for the region. In particular, we used maximum entropy and generalized additive modeling to delineate distribution and abundance of early (egg, larval, and pelagic juvenile) and later (settled juvenile and adult) life history stages of groundfishes and crabs across multiple seasons in three large marine ecosystems (Gulf of Alaska, eastern Bering Sea, and Aleutian Islands) and the northern Bering Sea. We present a case study, featuring Kamchatka flounder (Atheresthes evermanni), from the eastern and northern Bering Sea to represent the >400 habitat-based distribution maps generated for more than 80 unique species–region–season–life-stage combinations. The results of these studies will be used to redescribe essential habitat of federally managed fishes and crabs in Alaska.
BackgroundAs part of a randomised controlled trial of treatment with placebo versus 3 days of amoxicillin for nonsevere fast-breathing pneumonia among Malawian children aged 2–59 months, a subset of children was hospitalised for observation. We sought to characterise the progression of fast-breathing pneumonia among children undergoing repeat assessments to better understand which children do and do not deteriorate.MethodsVital signs and physical examination findings, including respiratory rate, arterial oxygen saturation measured by pulse oximetry (SpO2), chest indrawing and temperature were assessed every 3 h for the duration of hospitalisation. Children were assessed for treatment failure during study visits on days 1, 2, 3 and 4.ResultsHospital monitoring data from 436 children were included. While no children had SpO2 90–93% at baseline, 7.4% (16 of 215) of children receiving amoxicillin and 9.5% (21 of 221) receiving placebo developed SpO2 90–93% during monitoring. Similarly, no children had chest indrawing at enrolment, but 6.6% (14 of 215) in the amoxicillin group and 7.2% (16 of 221) in the placebo group went on to develop chest indrawing during hospitalisation.ConclusionRepeat monitoring of children with fast-breathing pneumonia identified vital and physical examination signs not present at baseline, including SpO2 90–93% and chest indrawing. This information may support providers and policymakers in developing guidance for care of children with nonsevere pneumonia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.